24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
15/10/2020
Parc de l'Alba in a WHO project
02/10/2020
The hydraulic barrier of Can Planas comes into operation
30/09/2020
SENER, the leading urban transport engineering company in Mexico
16/09/2020
Biogas injected into the natural gas grid: works begin!
23/07/2020
Catalan start-ups know how to attract funding
06/07/2020
The Barcelona Synchrotron Park joins the new WEDISTRICT EU program